Purchase Method vs Acquisition Method for Business Combinations: The ASC 805 Evolution (2026)

The single accounting policy shift that erased roughly $3 billion of capitalized in-process R&D, expensed billions more in deal fees, and remapped how every US public company books an acquisition is the purchase method vs acquisition method for business combinations distinction created when FASB Statement 141R replaced FASB Statement 141 for fiscal years beginning after December 15, 2008. The change codified into ASC 805 was not cosmetic. According to PwC’s 2025 Business Combinations Guide, six separate measurement areas flipped between the two methods, and each one moves goodwill, earnings, or the balance sheet in opposite directions on the same deal. For controllers and CFOs running deal models in 2026, the old purchase-method intuition is still embedded in legacy diligence templates, valuation memos, and board decks, which is why the wrong frame still produces wrong numbers seventeen years after the rule changed.

What This Actually Means

Before 2009, US GAAP filers booked acquisitions under two methods, depending on the facts. The pooling-of-interests method, sanctioned by APB Opinion 16 since 1970, let two combining companies simply carry forward their historical book values, with no goodwill, no asset step-up, and no recognition of fair value. The purchase method, also under APB 16 and later FASB Statement 141 issued in 2001, required the acquirer to allocate the purchase price across identifiable assets and liabilities at fair value, with the residual booked as goodwill. FASB Statement 142, issued the same day as Statement 141 in June 2001, then changed how that goodwill behaved by replacing the 40-year straight-line amortization with an annual impairment test. The combination of FAS 141 and FAS 142 is what killed pooling, because pooling’s main attraction had been avoiding a goodwill drag on future earnings.

FASB Statement 141R, issued in December 2007 and effective for fiscal years beginning after December 15, 2008, replaced the purchase method with the acquisition method. The IASB issued the parallel revised IFRS 3 the same year. The two boards published their revised standards together as a converged framework, with the deliberate intent of producing the same accounting answer on the same set of facts under US GAAP and IFRS. ASC 805 is the codified location of FAS 141R and its subsequent amendments, including ASU 2017-01 on the definition of a business, ASU 2018-07 on share-based payment in business combinations, and ASU 2021-08 on contract assets and liabilities acquired.

The acquisition method kept the broad architecture of the purchase method, including fair-value measurement and residual goodwill, but it changed six specific measurement areas. Each change pulled the answer toward what FASB called “the economic substance of the transaction at the acquisition date” rather than toward the historical cost-based, conservative posture of FAS 141. Understanding the six changes is the practical content of the purchase method vs acquisition method question, because in every other respect the two methods look similar at first glance.

The Six Measurement Changes That Define the Acquisition Method

1. Contingent Consideration: Day-1 Fair Value vs Pay-as-You-Go

Under the old purchase method, contingent consideration in the form of an earnout was generally not recognized at the acquisition date. The acquirer disclosed the contingency in the footnotes and waited. When the contingency was resolved and the payment became probable and estimable, the acquirer recorded the payment by increasing goodwill, dollar-for-dollar, in the period of resolution. There was no Day-1 measurement, no fair value estimate of the future payment, and no income statement impact from changes in expected value.

Under the acquisition method codified in ASC 805-30-25-5 and ASC 805-30-35-1, contingent consideration is measured at fair value at the acquisition date and recognized as part of the consideration transferred. That fair value goes into the goodwill calculation immediately. If the contingent consideration is classified as a liability, it is then re-measured at fair value at each reporting period until settlement, with changes flowing through earnings. If it is classified as equity, it is not re-measured. The classification turns on the formal terms of the earnout and whether it can be settled in a variable number of shares. According to EY’s 2025 Financial Reporting Developments guide on business combinations, the contingent consideration change is the single most common driver of post-deal earnings volatility for acquirers, particularly in life sciences and software, where milestone earnouts are routine.

2. Acquisition-Related Transaction Costs: Expensed vs Capitalized

The transaction cost treatment is the most visible P&L difference between the two methods, and it is the one that gets the most attention from acquirer CFOs in deal planning meetings. Under FAS 141, direct and incremental costs of an acquisition, including legal fees, accounting due diligence, investment banking advisory fees, broker commissions, and certain consulting fees, were capitalized into the cost of the acquired business. They became part of the goodwill calculation and were not separately expensed.

Under ASC 805-10-25-23 (the codified location of the FAS 141R rule), the acquirer expenses acquisition-related costs in the period in which the costs are incurred and the services are received. The only exception is the cost to issue debt or equity securities used as consideration, which continues to be accounted for under the existing guidance for debt issuance costs (ASC 835-30) or equity issuance costs (SAB Topic 5.A). For a $200 million strategic deal, Capstone Partners’ 2026 Q1 M&A Fee Guide puts typical advisory, legal, and diligence costs at 1.5 to 3 percent of enterprise value, which means $3 to $6 million of P&L expense that would have been capitalized into goodwill under the old purchase method now hits operating income in the quarter the deal closes.

3. In-Process Research and Development: Capitalized Intangible vs Immediate Write-Off

Under the purchase method, FASB Interpretation 4 required acquired in-process research and development (IPR&D) to be written off to expense at the acquisition date if the projects had no alternative future use. The result was a one-time Day-1 charge that often ran into the hundreds of millions of dollars on biotech and pharma deals. Companies and investors learned to back the IPR&D write-off out of GAAP earnings to compare deal-year performance to baseline. The write-off was a known feature of life sciences M&A from 1981 until 2008.

Under the acquisition method, ASC 805-20-25-1 and ASC 350-30-25-1 require IPR&D acquired in a business combination to be recognized at fair value as an indefinite-lived intangible asset. It is not amortized while it is indefinite-lived. It is tested for impairment annually under ASC 350. Once the underlying project is either completed or abandoned, the indefinite life classification ends. Completed projects are reclassified as finite-lived intangibles and amortized over their useful life. Abandoned projects are written off in the period of abandonment. KPMG’s 2025 Handbook on business combinations notes that the IPR&D rule was the single largest GAAP impact on pharma M&A accounting between the old and new methods, because the immediate write-off historically obscured tens of billions of dollars of acquired research value that now sits as an indefinite-lived intangible on acquirer balance sheets.

4. Noncontrolling Interest: Full Fair Value vs Proportionate Share

When an acquirer buys less than 100 percent of a target but obtains control, the remaining stake is called a noncontrolling interest (NCI), historically called a minority interest. The two methods measure NCI very differently. Under the purchase method, NCI was recorded at the noncontrolling shareholders’ proportionate share of the acquiree’s pre-combination book values, not fair value. Goodwill was recognized only on the controlling share. This produced what practitioners called “partial goodwill” or “controlling interest goodwill,” and it understated both the consolidated assets and the consolidated goodwill compared to a true economic view of the combined entity.

Under ASC 805-20-30-1 and ASC 810-10-45-15, the acquirer measures NCI at acquisition-date fair value. The result is “full goodwill” because the goodwill calculation includes both the controlling and noncontrolling shares of the acquired business. The exception is that the acquirer has a measurement election under ASC 805-20-30-7 for each business combination, allowing NCI to be measured either at fair value or at the noncontrolling interest’s proportionate share of the recognized identifiable net assets. Under IFRS 3, the same election exists. PwC’s 2025 guide reports that most US filers default to full fair value for NCI, but the proportionate-share option remains commonly elected in real estate and certain joint-venture-style deals where a public market price for the NCI is unavailable.

5. Restructuring Costs: Post-Acquisition Recognition vs Acquisition-Date Accrual

Under the purchase method, EITF 95-3 allowed the acquirer to record a liability at the acquisition date for the cost of an exit plan or restructuring plan affecting the acquired business, as long as the plan met specific criteria, including being formally adopted within one year. The accrual went into the purchase price allocation, which meant restructuring charges that would otherwise hit post-acquisition earnings were absorbed into goodwill on Day 1. Acquirers used this to insulate post-close P&L from severance, facility closure, and contract termination charges that were planned at the time of the deal.

Under the acquisition method, ASC 805-20-25-2 and related guidance require that a liability be recognized at the acquisition date only if it represents a present obligation of the acquiree that meets the recognition criteria of FASB Concepts Statement 6 as of the acquisition date. A plan that the acquirer expects to execute post-close is not a present obligation of the acquiree at the acquisition date and therefore is not part of the purchase price allocation. Instead, the restructuring is recognized in post-acquisition earnings under ASC 420 or ASC 712, with the related expense hitting the P&L when the criteria are met. This change forced acquirer integration teams to publicly absorb integration costs through reported earnings, which materially changed how restructuring was negotiated with audit committees and investors after 2009.

6. Bargain Purchase: Recognized Gain vs Pro-Rata Asset Reduction

A bargain purchase occurs when the fair value of identifiable net assets acquired exceeds the consideration transferred. Under the purchase method, FAS 141 required that the excess (called “negative goodwill”) be allocated pro-rata against the carrying values of acquired non-current non-financial assets, reducing the basis of property, plant, equipment, and finite-lived intangibles. Only after those assets were written down to zero did any remaining excess get recognized as an extraordinary gain. In practice, most bargain purchase situations were absorbed entirely into the asset write-down, with no current-period gain reported.

Under ASC 805-30-25-2 and ASC 805-30-25-4, a bargain purchase produces a gain that is recognized in earnings on the acquisition date, attributable to the acquirer. The acquirer is required to first reassess whether all assets and liabilities have been identified and measured correctly, since a true bargain purchase is rare and often signals a measurement error. If the reassessment confirms the bargain, the gain runs through the income statement immediately. AICPA’s 2024 Audit and Accounting Guide for Business Combinations notes that bargain purchase gains have appeared most often in distressed deals, FDIC-assisted bank acquisitions during the 2009-2012 cleanup cycle, and certain forced-sale transactions where the seller’s negotiating position was impaired.

Worked Example: A $100M Deal Booked Both Ways

The cleanest way to see the difference is to put a single hypothetical deal through both methods. Consider MidStrat Industrial Inc., a strategic acquirer, buying TargetCo, a niche industrial coatings business, for $100 million in cash at close, with a $20 million earnout tied to two-year revenue targets. Direct transaction costs total $5 million in legal, accounting, and investment banking fees. The target has $10 million of acquired IPR&D representing two unfinished coating formulations, both with alternative future use. Identifiable net assets at fair value, excluding IPR&D, total $55 million. The fair value of the earnout at the acquisition date, based on probability-weighted scenarios, is $14 million.

Under the old purchase method, the acquirer would have recorded $100 million of consideration on Day 1 (cash only, no earnout recognition). The $5 million of transaction costs would have been capitalized into the cost of the acquisition. The $10 million of IPR&D would have been written off to expense at close because, even though FIN 4 allowed capitalization for projects with alternative future use, many acquirers wrote off IPR&D conservatively. For the cleaner side-by-side, assume immediate write-off. Goodwill under the purchase method would be calculated as $100M consideration plus $5M capitalized costs, minus $55M identifiable net assets, minus $10M IPR&D written off, which produces goodwill of $40 million. Earnout payments, when made in years 1 and 2, would increase goodwill dollar-for-dollar on the payment date. If the earnout paid out at $20 million in full, goodwill would eventually grow to $60 million.

Under the acquisition method codified in ASC 805, the same deal books very differently. Consideration transferred on Day 1 is $100 million cash plus $14 million fair value of the contingent earnout, totaling $114 million. The $5 million of transaction costs is expensed immediately and never touches goodwill. The $10 million of IPR&D is recognized as an indefinite-lived intangible asset at fair value. Goodwill is calculated as $114M consideration minus $55M identifiable net assets minus $10M IPR&D intangible, producing goodwill of $49 million. If the earnout ultimately pays out at $20 million, the $6 million difference between the Day-1 fair value of $14 million and the final $20 million payment runs through earnings as a re-measurement loss over the earnout period. It does not change goodwill.

The two columns produce different goodwill balances, different income statements in the deal year, and different income statements in the post-close years. The same economic transaction, the same cash flows, the same value exchanged. The accounting method choice, when there was one, was the entire delta. After December 15, 2008, the choice was eliminated for US GAAP filers, but the legacy intuition still leaks into pre-deal modeling templates and post-deal reporting, which is the practical reason to understand both methods.

Why FASB Made the Change

FASB articulated four primary reasons for replacing the purchase method with the acquisition method in the basis for conclusions of Statement 141R. First, the board wanted the accounting to reflect the economic substance of the transaction at the acquisition date. The purchase method’s treatment of contingent consideration, transaction costs, and restructuring as either deferred or absorbed into goodwill obscured the actual exchange of value at close. The acquisition method’s Day-1 fair value approach was meant to put the full economic picture on the balance sheet immediately. Second, FASB wanted to converge with IFRS 3, which the IASB was also revising. The joint project produced standards that produce substantially the same accounting answer on the same facts, with the noncontrolling interest measurement election being the most visible remaining option-level difference.

Third, the board wanted to eliminate accounting choices that did not reflect underlying economics. Pooling of interests, abandoned by FAS 141 in 2001, had been the worst example. The purchase method’s treatment of transaction costs and contingent consideration created opportunities for similar earnings management that the acquisition method closed. Fourth, FASB wanted to improve comparability across acquirers. Under the old purchase method, two companies executing identical deals could report different earnings, different goodwill balances, and different post-deal performance trajectories, depending on the timing of contingent payments and the classification of transaction costs. The acquisition method’s mandatory Day-1 fair value measurement of consideration and immediate expensing of transaction costs produces more comparable financial statements across acquirers.

The convergence with IFRS 3 is worth flagging separately for US filers with international operations. IFRS 3 (Revised), issued by the IASB in January 2008 and effective for annual periods beginning on or after July 1, 2009, applies the same six measurement principles as ASC 805. The remaining option-level differences are narrow: NCI measurement election, the treatment of certain pre-existing relationships, and some scope exceptions. For cross-border deals, the converged framework means the same purchase price allocation can usually serve both US GAAP and IFRS reporting, which was not true under the pre-2009 standards.

Common Mistakes

Treating Earnouts as Off-Balance-Sheet Contingencies

The most common purchase-method holdover in deal models is treating earnouts as a disclosed contingency rather than a Day-1 fair value liability. Modelers anchored to the pre-2009 approach build acquisition accounting templates that omit the earnout from initial goodwill and then catch it in goodwill when paid. Under ASC 805, that approach understates Day-1 consideration, understates goodwill, and ignores the re-measurement noise that will hit the P&L every reporting period until the earnout settles. The fix is to require a Black-Scholes or probability-weighted scenario fair value of the earnout in the purchase price allocation memo, signed off by valuation specialists before the closing balance sheet is finalized.

Capitalizing Transaction Costs Into Goodwill

Audit teams still find acquirers who capitalize advisory fees into the cost of investment in consolidated subsidiary at the legal-entity level, which then rolls up into goodwill at consolidation. ASC 805-10-25-23 is unambiguous that acquisition-related costs are expensed in the period incurred. The exception for debt and equity issuance costs does not extend to advisory fees or due diligence costs even when the deal is financed with new debt or equity. Distinguishing the financing cost from the deal cost requires fee letters that allocate the work product, which most acquirers do not request from their advisors by default.

Writing Off IPR&D at Close

Pre-2009 muscle memory still produces deal models that write off acquired IPR&D as a Day-1 expense. Under the acquisition method, IPR&D acquired in a business combination is an indefinite-lived intangible asset until the project is completed or abandoned. The annual impairment test under ASC 350 replaces the immediate write-off. The mistake is most common in pharma and software deals where the seller’s books carried the development effort as an expense and the acquirer’s accounting team carries that historical treatment forward without re-evaluating under ASC 805.

Booking Planned Restructuring on Day 1

Integration teams that have built a 90-day restructuring plan around the deal sometimes push the audit team to accrue the restructuring liability at the acquisition date as part of the purchase price allocation. ASC 805-20-25-2 prohibits this. The restructuring is a post-acquisition decision of the new combined entity, not a present obligation of the acquiree at the acquisition date. The accrual goes through post-close earnings under ASC 420, not into goodwill. The mistake almost always inflates Day-1 goodwill and understates post-close operating income.

Recording Bargain Purchase Without a Reassessment

When a deal closes at a price below the fair value of identifiable net assets, the acquirer’s first move should be to reassess whether the asset and liability identification is complete and whether the fair value measurement is correct. ASC 805-30-25-4 requires this reassessment before any bargain purchase gain is recognized. A bargain purchase that survives reassessment is rare. A bargain purchase that did not survive a reassessment because the reassessment was never performed is a frequent restatement trigger, particularly in distressed-asset deals and forced sales.

Measuring NCI at Book Value

The NCI measurement election under ASC 805-20-30-7 is between fair value and proportionate share of identifiable net assets fair value, not between fair value and historical book value. Acquirers that record NCI at the seller’s historical carrying amount are using a purchase-method holdover that does not survive ASC 805. The election is made on a deal-by-deal basis and must be documented in the purchase price allocation memo.

Timeline: The Path From Purchase Method to ASC 805

1970: APB Opinion 16 codifies the two-method system, allowing both pooling of interests and the purchase method, depending on whether the deal meets twelve specific criteria (including a 90 percent stock-for-stock test). The pooling method becomes the preferred treatment for stock-financed mergers because it avoids goodwill recognition and the related earnings drag.

1981: FASB Interpretation 4 requires acquired in-process R&D with no alternative future use to be written off to expense at the acquisition date, establishing the IPR&D write-off practice that defines pharma and tech M&A accounting for the next 27 years.

2001 (June): FASB issues Statement 141 (Business Combinations) and Statement 142 (Goodwill and Other Intangible Assets) on the same day. FAS 141 eliminates pooling of interests, making the purchase method the only allowed treatment for new business combinations. FAS 142 replaces goodwill amortization with an annual impairment test, which removes the main remaining reason acquirers preferred pooling.

2007 (December): FASB issues Statement 141R, replacing the purchase method with the acquisition method effective for fiscal years beginning after December 15, 2008. The IASB issues the revised IFRS 3 in January 2008 with the same effective date in substance, creating a converged US GAAP and IFRS framework.

2009 (January): The acquisition method takes effect for calendar-year filers. Public companies begin booking deals under the new six-measurement-area framework. Transaction cost expense lines appear on income statements for the first time as separate disclosures.

2009 (July): ASC 805 is published as part of the FASB Accounting Standards Codification, becoming the official location of the acquisition method guidance. FAS 141R, FAS 141, APB 16, FIN 4, and EITF 95-3 are superseded but remain conceptually relevant for understanding the underlying changes.

2017 (January): FASB issues ASU 2017-01, narrowing the definition of a business and introducing the screen test that reclassifies many real estate and single-asset deals out of business combination accounting and into asset acquisition cost-accumulation. The classification call becomes a separate analytic step before the acquisition method even applies. See the related guide on the business combination vs asset acquisition classification under ASC 805 for the full breakdown of the screen test and the three-prong test.

2018-2021: A series of targeted amendments refine specific measurement areas, including ASU 2018-07 on share-based payment, ASU 2021-08 on contract assets and liabilities acquired (which carves out a revenue-contract exception to the Day-1 fair value rule), and ASU 2019-12 on simplifying income tax accounting in business combinations.

Frequently Asked Questions

Is the purchase method still allowed under US GAAP for any transactions?

No. The purchase method has been superseded for business combinations since fiscal years beginning after December 15, 2008. Asset acquisitions, which are accounted for under ASC 805-50, use a cost accumulation model that has some surface similarities to the old purchase method (transaction costs capitalized, no goodwill), but it is a separate model with its own rules. Common-control transactions under ASC 805-50 also use a different model based on carryover basis, not the acquisition method.

What is the difference between the purchase method and pooling of interests?

Pooling of interests, abandoned by FAS 141 in 2001, combined the historical book values of the two entities with no fair value step-up, no goodwill, and no transaction cost capitalization. The purchase method, the survivor of FAS 141 from 2001 to 2008, required the acquirer to allocate the purchase price across identifiable assets and liabilities at fair value, with the residual booked as goodwill. The acquisition method, the survivor since 2009, retains the fair value architecture but changes six specific measurement areas covered in this guide.

Do private companies have to apply the acquisition method?

Yes. The acquisition method applies to all entities that prepare financial statements under US GAAP, including private companies. The Private Company Council has issued alternatives within ASC 805 that simplify certain post-acquisition accounting (most notably the option to amortize goodwill over up to 10 years and to subsume customer-related intangibles into goodwill), but the core acquisition method itself is not optional.

How does the acquisition method affect the goodwill amortization decision?

Under US GAAP, public-company goodwill is not amortized. It is tested for impairment annually under ASC 350 (and on a triggering-event basis between annual tests). Private companies that elect the PCC alternative can amortize goodwill straight-line over up to 10 years and test for impairment only when a triggering event occurs. The acquisition method does not change this. The amortization decision is governed by ASC 350, not ASC 805. For more on how acquirers think about goodwill in deal modeling, see how goodwill is derived from an M&A transaction.

Does the acquisition method apply to mergers between private companies?

Yes, when the transaction meets the definition of a business combination under ASC 805. A merger of two private companies where one obtains control of the other is a business combination and applies the acquisition method. A merger of entities under common control uses a different model (carryover basis) under ASC 805-50. The various structural alternatives that count as a business combination are covered in the guide on types of mergers and acquisition.

How long does a typical purchase price allocation take under the acquisition method?

The measurement period under ASC 805-10-25-13 allows the acquirer up to one year from the acquisition date to finalize the purchase price allocation. In practice, complex deals with significant intangibles, contingent consideration, or unresolved tax positions often use the full year. Simpler deals with limited intangibles and no contingent consideration are typically finalized within 90 to 120 days. EY’s 2025 guide notes that public-company filers in the US typically disclose preliminary purchase price allocations in the first 10-Q after closing and final allocations within three to four quarters.

What to Do Next

If you are selling a business and want to understand how a strategic or PE buyer’s accounting team will frame the deal in committee, the practical move is to model the acquisition method outputs before the offer comes in. Buyers in 2026 are sensitive to the Day-1 P&L hit from transaction costs, the goodwill impact of contingent consideration, and the post-close earnings volatility from earnout re-measurement, all of which are products of the acquisition method, not the old purchase method. A well-structured deal anticipates these mechanics and presents them clearly in the data room.

CT Acquisitions works with both sides of the table on mid-market deals between $1M and $50M in revenue. We translate the ASC 805 mechanics into deal-structure language and help sellers anticipate how the buyer’s accounting will move the price they are willing to defend in committee. Buyers pay us, not you, which keeps the seller’s advisor incentive aligned with the seller’s outcome.